DIMENSIONAL FUND ADVISORS LP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,945,143
-20.6%
93,337
-8.8%
0.00%0.0%
Q2 2023$2,451,067
-0.0%
102,341
-21.4%
0.00%0.0%
Q1 2023$2,451,136
+48553.0%
130,241
-58.8%
0.00%0.0%
Q4 2022$5,038
-99.9%
316,464
-11.2%
0.00%
-50.0%
Q3 2022$5,830,000
-16.1%
356,415
-27.7%
0.00%0.0%
Q2 2022$6,946,000
-55.3%
492,928
-23.1%
0.00%
-60.0%
Q1 2022$15,531,000
+0.8%
641,223
-2.9%
0.01%0.0%
Q4 2021$15,411,000
+217.8%
660,252
+126.2%
0.01%
+150.0%
Q3 2021$4,850,000
-35.0%
291,887
-4.6%
0.00%0.0%
Q2 2021$7,462,000
-18.0%
305,996
-13.3%
0.00%
-33.3%
Q1 2021$9,102,000
-49.5%
352,817
+4.6%
0.00%
-57.1%
Q4 2020$18,025,000
+33.6%
337,147
+3.0%
0.01%
+16.7%
Q3 2020$13,493,000
-10.7%
327,217
+4.9%
0.01%
-14.3%
Q2 2020$15,116,000
+22.8%
311,907
+7.0%
0.01%
+16.7%
Q1 2020$12,306,000
-2.9%
291,404
-1.6%
0.01%
+20.0%
Q4 2019$12,674,000
+185.5%
296,224
+140.2%
0.01%
+150.0%
Q3 2019$4,440,000
+1175.9%
123,303
+968.2%
0.00%
Q4 2017$348,000
-89.5%
11,543
-86.9%
0.00%
-100.0%
Q3 2017$3,308,000
-51.6%
87,795
-55.8%
0.00%
-66.7%
Q1 2017$6,828,000
+3003.6%
198,620
+2500.1%
0.00%
Q4 2016$220,000
-96.9%
7,639
-96.6%
0.00%
-100.0%
Q3 2016$7,171,000
+65.6%
225,404
+68.9%
0.00%
+100.0%
Q2 2016$4,331,000
-19.4%
133,426
-11.4%
0.00%
-33.3%
Q4 2015$5,372,000
+9.1%
150,666
+1.2%
0.00%0.0%
Q3 2015$4,922,000
-17.3%
148,927
+4.8%
0.00%
-25.0%
Q2 2015$5,950,000
+59.0%
142,130
+23.8%
0.00%
+100.0%
Q1 2015$3,741,000
+104.8%
114,765
+99.4%
0.00%
+100.0%
Q4 2014$1,827,000
-58.8%
57,541
-67.6%
0.00%
-66.7%
Q4 2013$4,434,000177,4330.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders